Processa Pharmaceuticals, Inc.
PCSA • NASDAQ • Stock Fundamentals
Processa Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO George K. Ng, with a market cap of $6.5M.
Market Cap$6.5M
Employees13.0
CEOGeorge K. Ng
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026
View reportNext EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Processa Pharmaceuticals, Inc. FAQ
Common questions about Processa Pharmaceuticals, Inc.
Processa Pharmaceuticals, Inc. (PCSA) has a market capitalization of $6.5M and trades on NASDAQ.
Processa Pharmaceuticals, Inc. has approximately 13 employees.